# Garrett L. Walsh

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/garrett-l-walsh/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,848 |
| Field | Lung Cancer Diagnosis and Treatment |
| h-index | 75 |
| i10-index | 199 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5113764545 |
| Works | 316 |

## Researcher papers

- [Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial](https://scholariq.org/papers/neoadjuvant-nivolumab-or-nivolumab-plus-ipilimumab-in-operable-non-small-cell/)
- [Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer](https://scholariq.org/papers/effect-of-operative-volume-on-morbidity-mortality-and-hospital-use-after/)
- [Surgical Management of Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus](https://scholariq.org/papers/surgical-management-of-renal-cell-carcinoma-with-inferior-vena-cava-tumor/)

## Researcher topics

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Esophageal and GI Pathology](https://scholariq.org/topics/esophageal-and-gi-pathology/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.